Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 062246/0725 | |
| Pages: | 4 |
| | Recorded: | 12/30/2022 | | |
| Attorney Dkt #: | 6727-98940-11 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18147981
|
Filing Dt:
|
12/29/2022
|
|
Publication #:
|
|
Pub Dt:
|
07/13/2023
| | | | |
|
Title:
|
UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REACTIVE T CELLS FOR TREATMENT OF CANCER
|
|
|
Assignee
|
|
|
|
|
| 4805 NE GLISAN ST. |
| 2N35 |
| PORTLAND, OREGON 97213 |
|
|
Correspondence name and address
|
| |
KLARQUIST SPARKMAN, LLP
|
| |
121 SW SALMON STREET, SUITE 1600
|
| |
ONE WORLD TRADE CENTER
|
| |
PORTLAND, OR 97204
|
Search Results as of:
06/01/2024 01:00 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
